An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures

NCT00372528 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
21
Enrollment
INDUSTRY
Sponsor class

Stopped This study was terminated on April 8, 2011 as Pfizer Canada could no longer supply study drug. No efficacy or safety concerns factored into this decision.

Conditions

Interventions

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.